ISRCTN16366011已完成未知
Ambulatory oxygen for idiopathic pulmonary fibrosis
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 7
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Aged 18 or over
- •2. Clinically diagnosed IPF, confirmed by an ILD MDT linked to an NHS specialist commissioned IPF service
- •3. Breathlessness with MRC dyspnoea score =2
- •4. Willing and able to comply with completion of questionnaires out to 6 months post-randomisation
- •5. Able to complete a 6MWT or 1 minute sit to stand test
- •6. Able to use oxygen safely in the opinion of the local investigator
排除标准
- •1. Unable to provide informed consent
- •2. Requires LTOT, defined by need for resting oxygen in the opinion of the local investigator
- •3. Life expectancy <6 months
- •4. On the active transplant list
- •5. Previous acidotic hypercapnic respiratory failure (AHRF) requiring non-invasive ventilation (NIV)
研究者
相似试验
已完成
不适用
Acute Effects of Oxygen Supplementation Among IPF PatientsIdiopathic Pulmonary FibrosisNCT03688334George Papanicolaou Hospital15
已完成
不适用
PFOX: Pulmonary Fibrosis Ambulatory Oxygen TrialFibrotic Interstitial Lung DiseaseNCT03737409Monash University116
已完成
Unknown
A multi-centre study comparing idiopathic pulmonary fibrosis and combined pulmonary fibrosis and emphysemaISRCTN28134901Taichung Veterans General Hospital275
已完成
不适用
Hyperbaric oxygen as salvage treatment for idiopathic sudden sensorineural hearing loss.Sudden sensorineural hearing lossACTRN12613000952741Medical School of Aristotle University of Thessaloniki40
已完成
不适用
High Oxygen Delivery to Preserve Exercise Capacity in Idiopathic Pulmonary Fibrosis Patients Treated With NintedanibIdiopathic Pulmonary FibrosisNCT02551068University of British Columbia78